Pages that link to "Q30394806"
Jump to navigation
Jump to search
The following pages link to Adiponectin antagonizes the oncogenic actions of leptin in hepatocellular carcinogenesis (Q30394806):
Displaying 50 items.
- Honokiol activates AMP-activated protein kinase in breast cancer cells via an LKB1-dependent pathway and inhibits breast carcinogenesis (Q24614006) (← links)
- The integrative role of leptin, oestrogen and the insulin family in obesity-associated breast cancer: potential effects of exercise (Q26861527) (← links)
- Obesity-Related Digestive Diseases and Their Pathophysiology (Q28073381) (← links)
- Gender Differences in Adipocyte Metabolism and Liver Cancer Progression (Q28078472) (← links)
- Molecular mechanisms of cancer development in obesity (Q28253823) (← links)
- Adiponectin agonist ADP355 attenuates CCl4-induced liver fibrosis in mice (Q28543721) (← links)
- The anticancer and antiobesity effects of Mediterranean diet. (Q30244528) (← links)
- Obesity, adipokines and hepatocellular carcinoma (Q30427127) (← links)
- The diverse roles of adiponectin in non-small-cell lung cancer: current data and future perspectives (Q30984546) (← links)
- Multifaceted roles of adiponectin in cancer (Q33554797) (← links)
- Honokiol inhibits epithelial-mesenchymal transition in breast cancer cells by targeting signal transducer and activator of transcription 3/Zeb1/E-cadherin axis (Q33563809) (← links)
- Elevated serum visfatin levels are associated with poor prognosis of hepatocellular carcinoma (Q33618705) (← links)
- The effect of body mass index on survival in advanced epithelial ovarian cancer (Q33749184) (← links)
- GLP-1 Analogs Reduce Hepatocyte Steatosis and Improve Survival by Enhancing the Unfolded Protein Response and Promoting Macroautophagy (Q34034795) (← links)
- A prospective study of gynecological cancer risk in relation to adiposity factors: cumulative incidence and association with plasma adipokine levels (Q34035205) (← links)
- Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling (Q34104012) (← links)
- The role of adiponectin in cancer: a review of current evidence (Q34271986) (← links)
- Obesity and cancer--mechanisms underlying tumour progression and recurrence (Q34425077) (← links)
- Involvement of adiponectin in early stage of colorectal carcinogenesis (Q34515071) (← links)
- Serum adiponectin is associated with worsened overall survival in a prospective cohort of hepatocellular carcinoma patients (Q34765518) (← links)
- Signal transducer and activator of transcription 3 in liver diseases: a novel therapeutic target (Q34940989) (← links)
- Protracted upregulation of leptin and IGF1 is associated with activation of PI3K/Akt and JAK2 pathway in mouse intestine after ionizing radiation exposure (Q35069195) (← links)
- Hepatoprotective versus Oncogenic Functions of STAT3 in Liver Tumorigenesis (Q35167959) (← links)
- Metformin suppresses diethylnitrosamine-induced liver tumorigenesis in obese and diabetic C57BL/KsJ- Leprdb/ Leprdb mice (Q35447135) (← links)
- Autophagy induction by leptin contributes to suppression of apoptosis in cancer cells and xenograft model: involvement of p53/FoxO3A axis (Q35740174) (← links)
- Leptin-induced epithelial-mesenchymal transition in breast cancer cells requires β-catenin activation via Akt/GSK3- and MTA1/Wnt1 protein-dependent pathways (Q35868202) (← links)
- Paracrine and Endocrine Effects of Adipose Tissue on Cancer Development and Progression (Q36014897) (← links)
- Diabetes and Hepatitis C: A Two-Way Association (Q36056076) (← links)
- Biological Mechanisms for the Effect of Obesity on Cancer Risk: Experimental Evidence (Q36210928) (← links)
- Integral role of PTP1B in adiponectin-mediated inhibition of oncogenic actions of leptin in breast carcinogenesis (Q36567561) (← links)
- Targeting obesity-related adipose tissue dysfunction to prevent cancer development and progression (Q36680139) (← links)
- Role of adiponectin and its receptors in cancer (Q36814438) (← links)
- Evolving role of adiponectin in cancer-controversies and update (Q36849638) (← links)
- Obesity portends increased morbidity and earlier recurrence following liver transplantation for hepatocellular carcinoma (Q36953790) (← links)
- Cholesterol-induced mammary tumorigenesis is enhanced by adiponectin deficiency: role of LDL receptor upregulation (Q37381628) (← links)
- p27 Is a critical prognostic biomarker in non-alcoholic steatohepatitis-related hepatocellular carcinoma (Q37420848) (← links)
- Adiponectin deficiency contributes to the development and progression of benign prostatic hyperplasia in obesity (Q37678957) (← links)
- Excess body weight and obesity—the link with gastrointestinal and hepatobiliary cancer (Q37851004) (← links)
- Leptin promotes glioblastoma (Q37977441) (← links)
- Obesity and melanoma: exploring molecular links (Q38095892) (← links)
- Energy imbalance and cancer: Cause or consequence? (Q38429003) (← links)
- Hyperinsulinaemia and insulin signalling in the pathogenesis and the clinical course of hepatocellular carcinoma. (Q38540380) (← links)
- ADIPOQ/adiponectin induces cytotoxic autophagy in breast cancer cells through STK11/LKB1-mediated activation of the AMPK-ULK1 axis (Q38684517) (← links)
- Hepatocellular Carcinoma in Obesity, Type 2 Diabetes, and NAFLD. (Q38752448) (← links)
- Adiponectin and colorectal cancer (Q38803156) (← links)
- Hepatoma cell-derived leptin downregulates the immunosuppressive function of regulatory T-cells to enhance the anti-tumor activity of CD8 T-cells (Q38814170) (← links)
- Obesity and cancer: inflammation bridges the two. (Q38900947) (← links)
- FGF21 treatment ameliorates alcoholic fatty liver through activation of AMPK-SIRT1 pathway (Q38943985) (← links)
- Increased adiponectin associated with poor survival in hepatocellular carcinoma. (Q39077663) (← links)
- Obesity, but not ethanol, promotes tumor incidence and progression in a mouse model of hepatocellular carcinoma in vivo (Q39184063) (← links)